Skip to main content
logo
Ascendis Pharma A/S (FRA:A71)
Germany flag Germany · Delayed Price · Currency is EUR
180.00
+3.00 (1.69%)
At close: Jan 2, 2026

Ascendis Pharma Revenue

Ascendis Pharma had revenue of 213.63M EUR in the quarter ending September 30, 2025, with 269.40% growth. This brings the company's revenue in the last twelve months to 646.55M, up 97.46% year-over-year. In the year 2024, Ascendis Pharma had annual revenue of 363.64M with 36.34% growth.

Revenue (ttm)
646.55M
Revenue Growth
+97.46%
P/S Ratio
16.57
Revenue / Employee
635.74K
Employees
1,017
Market Cap
10.71B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024363.64M96.92M36.34%
Dec 31, 2023266.72M215.54M421.20%
Jan 1, 202351.17M43.40M557.93%
Dec 31, 20217.78M825.00K11.87%
Dec 31, 20206.95M-6.42M-48.01%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Mercedes-Benz Group AG136.97B
Bayerische Motoren Werke Aktiengesellschaft136.42B
Deutsche Telekom AG121.02B
Allianz SE105.02B
Siemens Aktiengesellschaft78.91B
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München62.10B
Siemens Energy AG39.08B
SAP SE36.49B
Revenue Rankings

Ascendis Pharma News

More News